Imbruvica

Generic name:ibrutinib [ eye-BROO-ti-nib ]
Drug class:BTK inhibitors

Medically reviewed by Jane Grigg, DipPharm. Last updated on May 31, 2021.

What is Imbruvica?

Imbruvica is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Imbruvica is used to treat mantle cell lymphoma, marginal zone lymphoma, Waldenstrom's macroglobulinemia, chronic lymphocytic leukemia, and small lymphocytic lymphoma.

Imbruvica is also used to treat chronic graft-versus-host disease.

Warnings

Imbruvica can make it easier for you to bleed. Contact your doctor or seek emergency medical attention if you have easy bruising, unusual bleeding, or any bleeding that will not stop.

Call your doctor at once if you have signs of bleeding inside your body, such as:dizziness, confusion, headache, speech problems, black or bloody stools, pink or brown urine, or coughing up blood or vomit that looks like coffee grounds.

Imbruvica also affects your immune system. You may get infections more easily, even serious or fatal infections. Tell your doctor if you have a fever, chills, cough, mouth sores, or other signs of infection.

Before taking this medicine

You should not use Imbruvica if you are allergic to ibrutinib.

To make sure Imbruvica is safe for you, tell your doctor if you have:

• an infection;

• liver disease;

• bleeding problems;

• a heart rhythm disorder; or

• risk factors for heart disease (such as diabetes,